Fejes-Toth G, Frölich J C, Naray-Fejes-Toth A
J Physiol. 1983 Jun;339:585-90. doi: 10.1113/jphysiol.1983.sp014735.
The renal response to arginine vasopressin was investigated with and without the simultaneous administration of the kallikrein inhibitor, aprotinin, in conscious Brattleboro homozygous rats with hereditary diabetes insipidus. Arginine vasopressin caused a marked antidiuretic response (urinary osmolality increased from 118 to 739 mosmol/l) which was accompanied by a significant increase in urinary prostaglandin excretion (prostaglandin E2 and F2 alpha excretion increased by 182 and 441%, respectively). Kallikrein excretion remained unchanged after arginine vasopressin infusion. The infusion of aprotinin diminished urinary kallikrein activity to undetectable levels, decreased potassium excretion significantly and caused a slight fall in urinary prostaglandin excretion. However, aprotinin failed to modify the arginine vasopressin-induced enhancement in prostaglandin excretion (prostaglandin E2 and F2 alpha excretion increased by 168 and 442%, respectively), and the antidiuretic response was also similar to that observed under control conditions. These results indicate that the kallikrein-kinin system is not involved in the renal response to vasopressin in the Brattleboro rat.
在遗传性尿崩症的清醒Brattleboro纯合大鼠中,研究了在同时给予激肽释放酶抑制剂抑肽酶和未给予该抑制剂的情况下,大鼠对精氨酸加压素的肾脏反应。精氨酸加压素引起明显的抗利尿反应(尿渗透压从118 mosmol/l增加到739 mosmol/l),同时尿前列腺素排泄显著增加(前列腺素E2和F2α排泄分别增加182%和441%)。输注精氨酸加压素后激肽释放酶排泄保持不变。输注抑肽酶可将尿激肽释放酶活性降低至检测不到的水平,显著减少钾排泄,并导致尿前列腺素排泄略有下降。然而,抑肽酶未能改变精氨酸加压素诱导的前列腺素排泄增加(前列腺素E2和F2α排泄分别增加168%和442%),并且抗利尿反应也与对照条件下观察到的相似。这些结果表明,激肽释放酶-激肽系统不参与Brattleboro大鼠对加压素的肾脏反应。